Associate Director, Viral Vector Process Development, Upstream

The Associate Director, Viral Vector Process Development (Upstream) at AstraZeneca leads the end-to-end design, development, and scale-up of Lentiviral Vector manufacturing processes within a high-performing Cell Therapy function. This role focuses on suspension bioreactor platforms from research through commercial readiness, managing strategy, execution, and cross-functional collaboration. The leader drives process innovations, validates scale-up strategies, and ensures GMP compliance while mentoring teams and managing external partners.